دورية أكاديمية
أعرض في EDS

Chitosan and Hydroxyapatite Based Biomaterials to Circumvent Periprosthetic Joint Infections.

التفاصيل البيبلوغرافية
العنوان: Chitosan and Hydroxyapatite Based Biomaterials to Circumvent Periprosthetic Joint Infections.
المؤلفون: Costa-Pinto AR; Universidade Católica Portuguesa, CBQF-Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal., Lemos AL; Universidade Católica Portuguesa, CBQF-Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal., Tavaria FK; Universidade Católica Portuguesa, CBQF-Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal., Pintado M; Universidade Católica Portuguesa, CBQF-Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.
المصدر: Materials (Basel, Switzerland) [Materials (Basel)] 2021 Feb 08; Vol. 14 (4). Date of Electronic Publication: 2021 Feb 08.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101555929 Publication Model: Electronic Cited Medium: Print ISSN: 1996-1944 (Print) Linking ISSN: 19961944 NLM ISO Abbreviation: Materials (Basel) Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: May 2010- : Basel, Switzerland : MDPI
Original Publication: Basel, Switzerland : Molecular Diversity Preservation International, 2008-2010.
مستخلص: Every year, worldwide, millions of people suffering from joint pain undergo joint replacement. For most patients, joint arthroplasty reduces pain and improve function, though a small fraction will experience implant failure. One of the main reasons includes prosthetic joint infection (PJI), involving the prosthesis and adjacent tissues. Few microorganisms (MO) are required to inoculate the implant, resulting in the formation of a biofilm on its surface. Standard treatment includes not only removal of the infected prosthesis but also the elimination of necrotic bone fragments, local and/or systemic administration of antibiotics, and revision arthroplasty with a new prosthesis, immediately after the infection is cleared. Therefore, an alternative to the conventional therapeutics would be the incorporation of natural antimicrobial compounds into the prosthesis. Chitosan (Ch) is a potential valuable biomaterial presenting properties such as biocompatibility, biodegradability, low immunogenicity, wound healing ability, antimicrobial activity, and anti-inflammatory potential. Regarding its antimicrobial activity, Gram-negative and Gram-positive bacteria, as well as fungi are highly susceptible to chitosan. Calcium phosphate (CaP)-based materials are commonly utilized in orthopedic and dentistry for their excellent biocompatibility and bioactivity, particularly in the establishment of cohesive bone bonding that yields effective and rapid osteointegration. At present, the majority of CaP-based materials are synthetic, which conducts to the depletion of the natural resources of phosphorous in the future due to the extensive use of phosphate. CaP in the form of hydroxyapatite (HAp) may be extracted from natural sources as fish bones or scales, which are by-products of the fish food industry. Thus, this review aims to enlighten the fundamental characteristics of Ch and HAp biomaterials which makes them attractive to PJI prevention and bone regeneration, summarizing relevant studies with these biomaterials to the field.
References: Biomatter. 2012 Oct-Dec;2(4):176-94. (PMID: 23507884)
Microbiol Mol Biol Rev. 2000 Dec;64(4):847-67. (PMID: 11104821)
Mater Sci Eng C Mater Biol Appl. 2010 Jan 30;30(2):295-303. (PMID: 30011620)
Int J Food Microbiol. 2010 Nov 15;144(1):51-63. (PMID: 20951455)
J Tissue Eng Regen Med. 2012 Jan;6(1):21-8. (PMID: 21312336)
J Arthroplasty. 2014 Sep;29(9):1774-8. (PMID: 25007726)
Clin Orthop Relat Res. 2008 Jul;466(7):1710-5. (PMID: 18421542)
Acta Biomater. 2010 Sep;6(9):3362-78. (PMID: 20167295)
Acta Biomater. 2008 Nov;4(6):1637-45. (PMID: 18635412)
Clin Infect Dis. 2013 Nov;57(9):1282-8. (PMID: 23912846)
Clin Chim Acta. 1974 Dec 17;57(3):205-9. (PMID: 4434640)
Biomaterials. 2006 Apr;27(11):2331-9. (PMID: 16364434)
Biotechnol Adv. 2011 Jan-Feb;29(1):67-74. (PMID: 20817088)
FEMS Immunol Med Microbiol. 2010 Aug;59(3):227-38. (PMID: 20412300)
Infect Dis Clin North Am. 2017 Jun;31(2):237-252. (PMID: 28366224)
Int J Antimicrob Agents. 2010 Apr;35(4):322-32. (PMID: 20149602)
RSC Adv. 2018 Jan 9;8(4):2015-2033. (PMID: 35542623)
Mater Sci Eng C Mater Biol Appl. 2013 Jan 1;33(1):103-10. (PMID: 25428050)
J Biomed Mater Res A. 2007 Sep 15;82(4):1022-32. (PMID: 17377965)
J Biomed Mater Res A. 2005 Nov 1;75(2):275-82. (PMID: 16044404)
Clin Orthop Relat Res. 2010 Jan;468(1):45-51. (PMID: 19554385)
J Nanobiotechnology. 2015 Jun 12;13:40. (PMID: 26065678)
J Bone Joint Surg Am. 2005 Mar;87(3):570-6. (PMID: 15741624)
Biomaterials. 1992;13(11):759-63. (PMID: 1391397)
Food Microbiol. 2008 Oct;25(7):922-8. (PMID: 18721683)
Biomaterials. 2013 Nov;34(33):8018-29. (PMID: 23932292)
J Biomed Mater Res B Appl Biomater. 2003 Oct 15;67(1):603-9. (PMID: 14528457)
J Appl Microbiol. 2008 Dec;105(6):1817-25. (PMID: 19016975)
Int J Biol Macromol. 2016 Apr;85:467-75. (PMID: 26780706)
CMAJ. 2016 Mar 1;188(4):243-244. (PMID: 26438015)
J Control Release. 2008 Sep 24;130(3):202-15. (PMID: 18687500)
Adv Exp Med Biol. 2017;971:93-100. (PMID: 28321829)
Acta Biomater. 2010 Oct;6(10):3815-23. (PMID: 20438869)
J Bone Joint Surg Br. 2012 May;94(5):619-23. (PMID: 22529080)
Adv Exp Med Biol. 2015;830:29-46. (PMID: 25366219)
Arthroplast Today. 2017 Jun 20;3(2):137-140. (PMID: 28695187)
Biomaterials. 1991 Jan;12(1):41-5. (PMID: 1849026)
Arthritis Rheum. 2002 Sep;46(9):2287-93. (PMID: 12355475)
Clin Microbiol Rev. 2002 Apr;15(2):155-66. (PMID: 11932228)
Tissue Eng Part A. 2008 Jun;14(6):1049-57. (PMID: 19230127)
Acta Orthop. 2011 Aug;82(4):417-22. (PMID: 21657972)
Biomaterials. 2004 Mar-Apr;25(7-8):1141-50. (PMID: 14643587)
J Diabetes Sci Technol. 2011 Mar 01;5(2):412-8. (PMID: 21527113)
Clin Dev Immunol. 2013;2013:387023. (PMID: 23533454)
Acta Orthop Scand. 2001 Dec;72(6):557-71. (PMID: 11817870)
J Arthroplasty. 2015 Sep;30(9):1492-7. (PMID: 25865815)
Clin Infect Dis. 2014 Jul 1;59(1):41-7. (PMID: 24723280)
Clin Infect Dis. 2001 Oct 15;33(8):1387-92. (PMID: 11565080)
J Bone Joint Surg Br. 2005 Jun;87(6):844-50. (PMID: 15911671)
Biomed Mater. 2019 Jun 19;14(4):045017. (PMID: 31170696)
Int J Pharm. 2002 Dec 5;249(1-2):165-74. (PMID: 12433445)
Nat Rev Microbiol. 2004 Feb;2(2):95-108. (PMID: 15040259)
J Orthop Surg Res. 2015 Oct 01;10:157. (PMID: 26429342)
J Biomed Mater Res A. 2012 Mar;100(3):599-612. (PMID: 22213676)
Chem Soc Rev. 2020 Aug 7;49(15):5178-5224. (PMID: 32642749)
Materials (Basel). 2020 Aug 26;13(17):. (PMID: 32859071)
Mater Sci Eng C Mater Biol Appl. 2019 Jun;99:999-1006. (PMID: 30889775)
Materials (Basel). 2019 Aug 22;12(17):. (PMID: 31443429)
Nat New Biol. 1973 Sep 19;245(142):78-80. (PMID: 4580792)
Int J Biol Macromol. 2009 Jul 1;45(1):12-5. (PMID: 19447253)
Proc Inst Mech Eng H. 2014 Oct;228(10):1083-99. (PMID: 25406229)
Tissue Eng Part B Rev. 2011 Oct;17(5):331-47. (PMID: 21810029)
Int J Food Microbiol. 2004 Sep 1;95(2):147-55. (PMID: 15282127)
J Biomed Mater Res. 1998 Fall;43(3):338-48. (PMID: 9730073)
J Hosp Infect. 2008 Nov;70 Suppl 2:3-10. (PMID: 19022115)
Int J Mol Sci. 2016 Oct 26;17(11):. (PMID: 27792192)
J Prev Med Hyg. 2016 Sep;57(3):E142-E148. (PMID: 27980378)
Morphologie. 2017 Sep;101(334):173-179. (PMID: 28501353)
Curr Rev Musculoskelet Med. 2018 Sep;11(3):332-340. (PMID: 29948954)
Drug Discov Today Technol. 2014 Mar;11:49-56. (PMID: 24847653)
J Funct Biomater. 2017 Jul 19;8(3):. (PMID: 28753925)
Carbohydr Polym. 2013 Mar 1;93(1):256-62. (PMID: 23465927)
Arch Ophthalmol. 2008 Nov;126(11):1572-81. (PMID: 19001227)
J Bone Joint Surg Am. 2007 Apr;89(4):780-5. (PMID: 17403800)
Phytopathology. 2009 Sep;99(9):1028-36. (PMID: 19671004)
N Engl J Med. 2009 Aug 20;361(8):787-94. (PMID: 19692690)
Clin Microbiol Rev. 2014 Apr;27(2):302-45. (PMID: 24696437)
EFORT Open Rev. 2019 Jul 29;4(7):482-494. (PMID: 31423332)
Open Orthop J. 2016 Nov 30;10:646-653. (PMID: 28144374)
Instr Course Lect. 2006;55:449-61. (PMID: 16958480)
J Biomed Mater Res. 2002 Mar 5;59(3):585-90. (PMID: 11774317)
Rheumatology (Oxford). 2007 Jul;46(7):1157-60. (PMID: 17478469)
J Arthroplasty. 2016 Jan;31(1):7-10. (PMID: 26304510)
J Mater Chem B. 2013 Feb 21;1(7):958-969. (PMID: 32262360)
Biomacromolecules. 2009 Aug 10;10(8):2067-73. (PMID: 19621927)
J Bone Joint Surg Am. 2013 May 1;95(9):775-82. (PMID: 23636183)
Int J Pharm. 2013 Oct 15;455(1-2):219-28. (PMID: 23886649)
Materials (Basel). 2016 Oct 19;9(10):. (PMID: 28773972)
J Arthroplasty. 2009 Sep;24(6 Suppl):105-9. (PMID: 19493644)
Calcif Tissue Int. 2017 Oct;101(4):341-354. (PMID: 28612084)
J Intern Med. 2014 Aug;276(2):111-9. (PMID: 24605880)
Materials (Basel). 2017 Mar 24;10(4):. (PMID: 28772697)
Bone. 2016 May;86:119-30. (PMID: 26946132)
Instr Course Lect. 1993;42:349-51. (PMID: 8463684)
Nat Rev Microbiol. 2018 Jul;16(7):397-409. (PMID: 29720707)
Infection. 2015 Dec;43(6):629-37. (PMID: 26096951)
J R Soc Interface. 2007 Dec 22;4(17):999-1030. (PMID: 17412675)
Acta Pharmacol Sin. 2004 Jul;25(7):932-6. (PMID: 15210068)
Clin Orthop Relat Res. 2001 Nov;(392):15-23. (PMID: 11716377)
Int J Food Microbiol. 2007 Feb 15;113(3):258-62. (PMID: 17084932)
Ann Rheum Dis. 2014 Jul;73(7):1323-30. (PMID: 24553908)
Biomaterials. 2001 Nov;22(22):2959-66. (PMID: 11575470)
J Am Dent Assoc. 2007 Nov;138(11):1476-84. (PMID: 17974645)
Biomaterials. 2011 Dec;32(36):9719-29. (PMID: 21925727)
ACS Appl Mater Interfaces. 2017 Feb 8;9(5):5023-5030. (PMID: 28133966)
Future Microbiol. 2014;9(8):987-1007. (PMID: 25302955)
J Bone Joint Surg Am. 2004 May;86(5):963-74. (PMID: 15118039)
Surgeon. 2015 Feb;13(1):52-8. (PMID: 25453272)
Clin Microbiol Infect. 2014 Feb;20(2):130-5. (PMID: 23573834)
J Biomed Mater Res. 1996 Dec;32(4):527-32. (PMID: 8953142)
Lancet. 2016 Jan 23;387(10016):386-394. (PMID: 26135702)
J R Soc Interface. 2008 Oct 6;5(27):1137-58. (PMID: 18667387)
معلومات مُعتمدة: Multibiorefinery - project ner 016403 Fundação para a Ciência e Tecnologia
فهرسة مساهمة: Keywords: antimicrobial; biomaterials; chitosan; hydroxyapatite; osteoregeneration; periprosthetic joint infection
تواريخ الأحداث: Date Created: 20210211 Latest Revision: 20240331
رمز التحديث: 20240331
مُعرف محوري في PubMed: PMC7914941
DOI: 10.3390/ma14040804
PMID: 33567675
قاعدة البيانات: MEDLINE
الوصف
تدمد:1996-1944
DOI:10.3390/ma14040804